DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
-3.27%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.01B
AUM Growth
+$262M
(+4.6%)
Cap. Flow
-$204M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159
Top Buys
| 1 |
WAY
Waystar Holding Corp
WAY
|
$106M |
| 2 |
Gilead Sciences
GILD
|
$102M |
| 3 |
CVS Health
CVS
|
$57.6M |
| 4 |
Baxter International
BAX
|
$52.6M |
| 5 |
Cullinan Oncology
CGEM
|
$37.4M |
Top Sells
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$136M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$80.7M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$63.2M |
| 4 |
Oscar Health
OSCR
|
$38.2M |
| 5 |
Viking Therapeutics
VKTX
|
$38M |
Sector Composition
| 1 | Healthcare | 83.29% |
| 2 | Industrials | 0.67% |
| 3 | Technology | 0.57% |
| 4 | Financials | 0.44% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
LifeMD
LFMD
$287M
| $276K | ﹤0.01% |
40,289
+8,204
| +26% | +$56.3K |
|
352
Tarsus Pharmaceuticals
TARS
$2.43B
| $273K | ﹤0.01% |
+10,034
| New | +$273K |
|
353
Brighthouse Financial
BHF
$2.48B
| $270K | ﹤0.01% |
6,219
-1,301
| -17% | -$56.4K |
|
|
DHC
354
Diversified Healthcare Trust
DHC
$995M
| $269K | ﹤0.01% |
88,223
+4,055
| +5% | +$12.4K |
|
355
FNB Corp
FNB
$5.92B
| $266K | ﹤0.01% |
+19,421
| New | +$266K |
|
356
Amphastar Pharmaceuticals
AMPH
$1.37B
| $265K | ﹤0.01% |
+6,623
| New | +$265K |
|
357
Replimune Group
REPL
$494M
| $264K | ﹤0.01% |
29,300
-773,684
| -96% | -$6.96M |
|
|
VSTO
358
DELISTED
Vista Outdoor Inc.
VSTO
| $262K | ﹤0.01% |
+6,967
| New | +$262K |
|
359
DXC Technology
DXC
$2.65B
| $260K | ﹤0.01% |
13,613
-48,632
| -78% | -$928K |
|
360
Copart
CPRT
$47B
| $258K | ﹤0.01% |
+4,762
| New | +$258K |
|
361
Fidelity National Information Services
FIS
$35.9B
| $258K | ﹤0.01% |
+3,417
| New | +$258K |
|
362
Mr. Cooper
COOP
$13.6B
| $257K | ﹤0.01% |
+3,164
| New | +$257K |
|
363
Federal Realty Investment Trust
FRT
$8.86B
| $255K | ﹤0.01% |
+2,521
| New | +$255K |
|
364
Kemper
KMPR
$3.39B
| $250K | ﹤0.01% |
+4,220
| New | +$250K |
|
365
Civitas Resources
CIVI
$3.19B
| $250K | ﹤0.01% |
+3,625
| New | +$250K |
|
366
PayPal
PYPL
$65.2B
| $250K | ﹤0.01% |
4,307
-1,908
| -31% | -$111K |
|
367
UnitedHealth
UNH
$286B
| $250K | ﹤0.01% |
490
| – | – |
|
368
Materion
MTRN
$2.33B
| $247K | ﹤0.01% |
+2,287
| New | +$247K |
|
369
Robinhood
HOOD
$90B
| $246K | ﹤0.01% |
+10,823
| New | +$246K |
|
370
Alphabet (Google) Class A
GOOGL
$2.84T
| $244K | ﹤0.01% |
1,340
-304
| -18% | -$55.4K |
|
371
Chevron
CVX
$310B
| $244K | ﹤0.01% |
+1,559
| New | +$244K |
|
372
Cigna
CI
$81.5B
| $244K | ﹤0.01% |
+737
| New | +$244K |
|
373
Forward Air
FWRD
$916M
| $242K | ﹤0.01% |
+12,703
| New | +$242K |
|
374
Bank of America
BAC
$369B
| $240K | ﹤0.01% |
+6,029
| New | +$240K |
|
375
Cytokinetics
CYTK
$6.34B
| $237K | ﹤0.01% |
4,366
-1,398
| -24% | -$75.7K |
|